Literature DB >> 23307416

Organic anion transporting polypeptides expressed in pancreatic cancer may serve as potential diagnostic markers and therapeutic targets for early stage adenocarcinomas.

Amanda Hays1, Udayan Apte, Bruno Hagenbuch.   

Abstract

PURPOSE: Organic Anion Transporting Polypeptides (OATPs) are expressed in various epithelial tissues in the body. Because they can be expressed in cancers and because they can transport anticancer drugs, OATPs could be potential targets for cancer therapy. Therefore we examined their expression in human pancreatic ductal adenocarcinomas.
METHODS: Expression of all 11 human OATPs was measured at the mRNA level and OATPs with highest expression were characterized at the protein level.
RESULTS: Transcripts of SLCO1B3, SLCO2A1, SLCO3A1 and SLCO4A1 were detected in all the tested pancreatic tissues. OATP1B3, OATP2A1, OATP3A1 and OATP4A1 protein expression was confirmed in these tissues and expression of all four transporters increased in pancreatic adenocarcinoma compared to normal pancreas. OATP1B3 expression was highest in pancreatic hyperplasia and stage one adenocarcinomas compared to stage two and three adenocarcinomas.
CONCLUSION: OATP1B3, OATP2A1, OATP3A1 and OATP4A1 are up-regulated in pancreatic adenocarcinoma and could potentially be used to target anticancer drugs to pancreatic cancer. Additionally, because expression of OATP1B3 is highest in pancreatitis and stage one adenocarcinoma, which leads to pancreatic cancer, OATP1B3 is a potential marker to diagnose patients with early stage pancreatic adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307416      PMCID: PMC3638072          DOI: 10.1007/s11095-012-0962-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3.

Authors:  Keiji Shimizu; Tadayuki Takashima; Tomohiko Yamane; Masahiro Sasaki; Hiromitsu Kageyama; Yoshinobu Hashizume; Kazuya Maeda; Yuichi Sugiyama; Yasuyoshi Watanabe; Michio Senda
Journal:  Nucl Med Biol       Date:  2012-03-14       Impact factor: 2.408

3.  Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts.

Authors:  Richard Liedauer; Martin Svoboda; Katrin Wlcek; Ferdi Arrich; Walter Jä; Cyril Toma; Theresia Thalhammer
Journal:  Oncol Rep       Date:  2009-12       Impact factor: 3.906

4.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

Authors:  I Tamai; J Nezu; H Uchino; Y Sai; A Oku; M Shimane; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

5.  Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells.

Authors:  Takashi Nozawa; Masato Suzuki; Hikaru Yabuuchi; Masanori Irokawa; Akira Tsuji; Ikumi Tamai
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

6.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

Review 7.  Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.

Authors:  Ying Huang; Wolfgang Sadée
Journal:  Cancer Lett       Date:  2005-10-05       Impact factor: 8.679

Review 8.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

9.  Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults.

Authors:  Simon Daenen; Bronno van der Holt; Gregor E G Verhoef; Bob Löwenberg; Pierre W Wijermans; Peter C Huijgens; Rien van Marwijk Kooy; Harry C Schouten; Mark H H Kramer; Augustin Ferrant; Eva van den Berg; Monique M C Steijaert; Leo F Verdonck; Pieter Sonneveld
Journal:  Leuk Res       Date:  2004-10       Impact factor: 3.156

Review 10.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

View more
  15 in total

Review 1.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

2.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2017-08-17       Impact factor: 4.304

3.  Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.

Authors:  Michelle Kim; Perri Deacon; Rommel G Tirona; Richard B Kim; Christopher L Pin; Henriette E Meyer Zu Schwabedissen; Rennian Wang; Ute I Schwarz
Journal:  Histochem Cell Biol       Date:  2017-05-10       Impact factor: 4.304

Review 4.  Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.

Authors:  Nilay Thakkar; A Craig Lockhart; Wooin Lee
Journal:  AAPS J       Date:  2015-03-04       Impact factor: 4.009

Review 5.  Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.

Authors:  Rachael R Schulte; Richard H Ho
Journal:  Mol Pharmacol       Date:  2019-02-19       Impact factor: 4.436

6.  LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1.

Authors:  Kun Wu; Ting Xu; Xudong Song; Jie Shen; Shutao Zheng; Li Zhang; Guoquan Tao; Baofei Jiang
Journal:  Lab Invest       Date:  2021-05-06       Impact factor: 5.662

7.  Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells.

Authors:  Timo H J Niedermeyer; Abigail Daily; Monika Swiatecka-Hagenbruch; Jeffrey A Moscow
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

8.  Association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C polymorphisms and overall survival of breast cancer patients after tamoxifen therapy.

Authors:  Xuefeng Zhang; Zhichen Pu; Jun Ge; Jie Shen; Xiaolong Yuan; Haitang Xie
Journal:  Med Sci Monit       Date:  2015-02-21

9.  Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers.

Authors:  Yuchen Sun; Tomomi Furihata; Seiya Ishii; Miki Nagai; Manami Harada; Osamu Shimozato; Takehiko Kamijo; Shinichiro Motohashi; Ichiro Yoshino; Atsuko Kamiichi; Kaoru Kobayashi; Kan Chiba
Journal:  Clin Transl Med       Date:  2014-11-18

10.  Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.

Authors:  Yuanyuan Li; Phillip Buckhaults; Xiangqin Cui; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2016-08-01       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.